BA
RPRX

BlackRock Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

BlackRock Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6K Hold
4,528
– – ﹤0.01% 3627
2016
Q3 		$9K Hold
4,528
– – ﹤0.01% 3602
2016
Q2 		$7K Hold
4,528
– – ﹤0.01% 3641
2016
Q1 		$4K Hold
4,528
– – ﹤0.01% 3709
2015
Q4 		$5K Hold
4,528
– – ﹤0.01% 3737
2015
Q3 		$34K Hold
4,528
– – ﹤0.01% 3400
2015
Q2 		$32K Sell
4,528
-11,824
-72% -$92.1K ﹤0.01% 3399
2015
Q1 		$140K Buy
16,352
+2,249
+16% +$20.1K ﹤0.01% 2887
2014
Q4 		$141K Hold
14,103
– – ﹤0.01% 2849
2014
Q3 		$140K Sell
14,103
-845
-6% -$12.5K ﹤0.01% 2820
2014
Q2 		$259K Sell
14,948
-1,927
-11% -$31.4K ﹤0.01% 2475
2014
Q1 		$299K Buy
16,875
+1,224
+8% +$23.7K ﹤0.01% 2403
2013
Q4 		$286K Buy
15,651
+1,305
+9% +$24.6K ﹤0.01% 2428
2013
Q3 		$384K Buy
14,346
+2,972
+26% +$63.7K ﹤0.01% 2118
2013
Q2 		$210K Buy
+11,374
New +$201K ﹤0.01% 2444

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Advisors's RPRX Position: Q4 2016 in Review

BlackRock Advisors held its Repros Therapeutics Inc. (RPRX) position steady in Q4 2016 at 4,528 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3627.

BlackRock Advisors first reported a position in RPRX in Q2 2013 and has held it in 15 quarters since. The position peaked at $384K in Q3 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

  • BlackRock Advisors held 4,528 shares of Repros Therapeutics Inc. worth $6K as of Q4 2016.
  • BlackRock Advisors left its Repros Therapeutics Inc. share count unchanged in Q4 2016.
  • Repros Therapeutics Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3627 holding.
  • BlackRock Advisors first reported a position in Repros Therapeutics Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Repros Therapeutics Inc. position peaked at $384K in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.